These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22211368)

  • 41. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overnight suppression of HPA axis after mineraolocorticoid receptor stimulation: A sleep endocrine study.
    Demiralay C; Agorastos A; Jahn H; Kellner M; Yassouridis A; Wiedemann K
    Psychiatry Res; 2015 May; 227(1):65-70. PubMed ID: 25799272
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mineralocorticoid receptor function in posttraumatic stress disorder after pretreatment with metyrapone.
    Otte C; Muhtz C; Daneshkhah S; Yassouridis A; Kiefer F; Wiedemann K; Kellner M
    Biol Psychiatry; 2006 Oct; 60(7):784-7. PubMed ID: 16566900
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cortisol hypersecretion in unipolar major depression with melancholic and psychotic features: dopaminergic, noradrenergic and thyroid correlates.
    Duval F; Mokrani MC; Monreal-Ortiz JA; Fattah S; Champeval C; Schulz P; Macher JP
    Psychoneuroendocrinology; 2006 Aug; 31(7):876-88. PubMed ID: 16769179
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elevated plasma 19-hydroxyandrostenedione levels in Cushing's disease: stimulation with ACTH and inhibition with metyrapone.
    Mune T; Morita H; Yasuda K; Murayama M; Yamakita N; Miura K
    Clin Endocrinol (Oxf); 1993 Mar; 38(3):265-72. PubMed ID: 8384536
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypothalamic-pituitary adrenal response to cholecystokinin-B receptor agonism is resistant to cortisol feedback inhibition.
    Abelson JL; Young EA
    Psychoneuroendocrinology; 2003 Feb; 28(2):169-80. PubMed ID: 12510010
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patients with Cushing's disease secrete adrenocorticotropin and cortisol jointly more asynchronously than healthy subjects.
    Roelfsema F; Pincus SM; Veldhuis JD
    J Clin Endocrinol Metab; 1998 Feb; 83(2):688-92. PubMed ID: 9467594
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low early morning plasma cortisol in posttraumatic stress disorder is associated with co-morbid depression but not with enhanced glucocorticoid feedback inhibition.
    Vythilingam M; Gill JM; Luckenbaugh DA; Gold PW; Collin C; Bonne O; Plumb K; Polignano E; West K; Charney D
    Psychoneuroendocrinology; 2010 Apr; 35(3):442-50. PubMed ID: 19766403
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypothalamic-pituitary-adrenal axis activation in obstructive sleep apnea: the effect of continuous positive airway pressure therapy.
    Henley DE; Russell GM; Douthwaite JA; Wood SA; Buchanan F; Gibson R; Woltersdorf WW; Catterall JR; Lightman SL
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4234-42. PubMed ID: 19820009
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Continuous administration of human corticotropin-releasing hormone in the absence of glucocorticoid feedback in man.
    Ur E; Capstick C; McLoughlin L; Checkley S; Besser GM; Grossman A
    Neuroendocrinology; 1995 Feb; 61(2):191-7. PubMed ID: 7753338
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diminished cortisol levels in subordinate female marmosets are associated with altered central drive to the hypothalamic-pituitary-adrenal axis.
    Saltzman W; Hogan BK; Abbott DH
    Biol Psychiatry; 2006 Oct; 60(8):843-9. PubMed ID: 16499881
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of ovine corticotropin-releasing hormone on adrenocorticotropin secretion in the absence of glucocorticoid feedback inhibition in man.
    Debold CR; Jackson RV; Kamilaris TC; Sheldon WR; Decherney GS; Island DP; Orth DN
    J Clin Endocrinol Metab; 1989 Feb; 68(2):431-7. PubMed ID: 2537333
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diminished and irregular TSH secretion with delayed acrophase in patients with Cushing's syndrome.
    Roelfsema F; Pereira AM; Biermasz NR; Frolich M; Keenan DM; Veldhuis JD; Romijn JA
    Eur J Endocrinol; 2009 Nov; 161(5):695-703. PubMed ID: 19687167
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Normal and abnormal function of the hypothalamic-pituitary-adrenocortical system in man.
    Streeten DH; Anderson GH; Dalakos TG; Seeley D; Mallov JS; Eusebio R; Sunderlin FS; Badawy SZ; King RB
    Endocr Rev; 1984; 5(3):371-94. PubMed ID: 6088218
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immune and endocrine mechanisms of advanced cancer-related hypercortisolemia.
    Lissoni P; Brivio F; Fumagalli L; Messina G; Secreto G; Romelli B; Fumagalli G; Rovelli F; Colciago M; Brera G
    In Vivo; 2007; 21(4):647-50. PubMed ID: 17708360
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [ACTH secretion and adrenocortical responsiveness in Cushing's syndrome due to adrenocortical hyperplasia (author's transl)].
    Suzuki S
    Nihon Naibunpi Gakkai Zasshi; 1976 Aug; 52(8):828-44. PubMed ID: 190054
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of carbamazepine on pituitary-adrenal function in healthy volunteers.
    Perini GI; Devinsky O; Hauser P; Gallucci WT; Theodore WH; Chrousos GP; Gold PW; Kling MA
    J Clin Endocrinol Metab; 1992 Feb; 74(2):406-12. PubMed ID: 1309836
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
    Tsagarakis S; Vasiliou V; Kokkoris P; Stavropoulos G; Thalassinos N
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combined stimulation of adrenocorticotropin and compound-S by single dose metyrapone test as an outpatient procedure to assess hypothalamic-pituitary-adrenal function.
    Berneis K; Staub JJ; Gessler A; Meier C; Girard J; Müller B
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5470-5. PubMed ID: 12466339
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
    Cleare AJ; Miell J; Heap E; Sookdeo S; Young L; Malhi GS; O'Keane V
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.